Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides in particular base contexts (CpG-S motifs) are relatively common in bacterial DNA but are rare in vertebrate DNA. B cells and monocytes have the ability to detect such CpG-S motifs that trigger innate immune defenses with production of Th1-like cytokines. Despite comparable levels of unmethylated CpG dinucleotides, DNA from serotype 12 adenovirus is immune-stimulatory, but serotype 2 is nonstimulatory and can even inhibit activation by bacterial DNA. In type 12 genomes, the distribution of CpG-flanking bases is similar to that predicted by chance. However, in type 2 adenoviral DNA the immune stimulatory CpG-S motifs are outnumbered by a 15- to 30-fold excess of CpG dinucleotides in clusters of direct repeats or with a C on the 5′ side or a G on the 3′ side. Synthetic oligodeoxynucleotides containing these putative neutralizing (CpG-N) motifs block immune activation by CpG-S motifs in vitro and in vivo. Eliminating 52 of the 134 CpG-N motifs present in a DNA vaccine markedly enhanced its Th1-like function in vivo, which was increased further by the addition of CpG-S motifs. Thus, depending on the CpG motif, prokaryotic DNA can be either immune-stimulatory or neutralizing. These results have important implications for understanding microbial pathogenesis and molecular evolution and for the clinical development of DNA vaccines and gene therapy vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationKlinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., & Krieg, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2879 · Cited by 1,477
Self-citationImmunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., & Raz, E. (1996) · Science · doi:10.1126/science.273.5273.352 · Cited by 1,058
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Self-citationDonnelly, J. J., Ulmer, J. B., Shiver, J. W., & Liu, M. A. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.617 · Cited by 987
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., & Raz, E. (1997) · Nature Medicine · doi:10.1038/nm0897-849 · Cited by 908
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Self-citationCpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
Self-citationMacrophages ingest and are activated by bacterial DNA
Stacey, K. J., Sweet, M. J., & Hume, D. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2116 · Cited by 570
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Self-citationRaz, E., Tighe, H., Sato, Y., Corr, M., Dudler, J. A., Roman, M., Swain, S. L., Spiegelberg, H. L., & Carson, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.5141 · Cited by 515
Contribution of CpG motifs to the immunogenicity of DNA vaccines
Klinman, D. M., Yamshchikov, G., & Ishigatsubo, Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3635 · Cited by 507
Cowdery, J. S., Chace, J. H., Yi, A. K., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4570 · Cited by 423
Self-citationMacrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock
Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Häcker, H., Heeg, K., & Wagner, H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270712 · Cited by 416
Halpern, M. D., Kurlander, R. J., & Pisetsky, D. S. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0009 · Cited by 391
Lipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H., & Heeg, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270931 · Cited by 383
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Davis, H. L., Whalen, R. G., & Demeneix, B. A. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.2-151 · Cited by 371
Self-citationYi, A.-K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4755 · Cited by 328
Self-citationKarlin, S., Doerfler, W., & Cardon, L. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2889-2897.1994 · Cited by 326
Letvin, N. L., Montefiori, D. C., Yasutomi, Y., Perry, H. C., Davies, M.-E., Lekutis, C., Alroy, M., Freed, D. C., Lord, C. I., Handt, L. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9378 · Cited by 312
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
Moldoveanu, Z., Love-Homan, L., Huang, W. Q., & Krieg, A. M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80122-9 · Cited by 310
Self-citationBacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., & Cowdery, J. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4380 · Cited by 291
Self-citationYi, A. K., Klinman, D. M., Martin, T. L., Matson, S., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5394 · Cited by 281
Self-citationZabner, J., Ramsey, B. W., Meeker, D. P., Aitken, M. L., Balfour, R. P., Gibson, R. L., Launspach, J., Moscicki, R. A., Richards, S. M., & Standaert, T. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118573 · Cited by 265
CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.
Schwartz, D. A., Quinn, T. J., Thorne, P. S., Sayeed, S., Yi, A. K., & Krieg, A. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119523 · Cited by 254
Self-citationThe role of CpG dinucleotides in DNA vaccines
Krieg, A. M., Yi, A.-K., Schorr, J., & Davis, H. L. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01145-1 · Cited by 248
Self-citationYi, A.-K., Chang, M., Peckham, D. W., Krieg, A. M., & Ashman, R. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5898 · Cited by 241
Self-citationSimian immunodeficiency virus DNA vaccine trial in macaques
Lu, S., Arthos, J., Montefiori, D. C., Yasutomi, Y., Manson, K., Mustafa, F., Johnson, E., Santoro, J. C., Wissink, J., Mullins, J. I., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3978-3991.1996 · Cited by 239
Immunization of non-human primates with DNA vaccines
Liu, M. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00280-0 · Cited by 215
Yi, A. K., Chace, J. H., Cowdery, J. S., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.558 · Cited by 206
Self-citationYamamoto, S., Kuramoto, E., Shimada, S., & Tokunaga, T. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb00049.x · Cited by 204
Zabner, J., Cheng, S. H., Meeker, D., Launspach, J., Balfour, R., Perricone, M. A., Morris, J. E., Marshall, J., Fasbender, A., Smith, A. E., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119676 · Cited by 176
Wang, C., Chao, L., & Chao, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117847 · Cited by 141
Yi, A., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1240 · Cited by 133
Self-citationGroup C adenovirus DNA sequences in human lymphoid cells
Horváth, J. K., Palkonyay, L., & WEBER, J. M. (1986) · Journal of Virology · doi:10.1128/jvi.59.1.189-192.1986 · Cited by 131
Inactivation of the Very Strong HCMV Immediate Early Promoter by DNA CpG Methylation In Vitro
Prösch, S., Stein, J., Staak, K., Liebenthal, C., Volk, H.-D., & Krüger, D. H. (1996) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1996.377.3.195 · Cited by 123
Mitogenicity of DNA from different organisms for murine B cells
Sun, S., Beard, C., Jaenisch, R., Jones, P. A., & Sprent, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3119 · Cited by 122
Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human Primates
Parker, S. E., Vahlsing, H. L., Serfilippi, L. M., Franklin, C. L., Doh, S. G., Gromkowski, S. H., Lew, D., Manthorpe, M., & Norman, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.5-575 · Cited by 109
Simultaneous Introduction of Multiple Mutations Using Overlap Extension PCR
Ge, L., & Rudolph, P. (1997) · BioTechniques · doi:10.2144/97221bm03 · Cited by 90
Gramzinski, R. A., Millan, C. L. B., Obaldía, N., Hoffman, S. L., & Davis, H. L. (1998) · Molecular Medicine · doi:10.1007/bf03401734 · Cited by 85
Self-citationShpaer, E. G., & Mullins, J. I. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.19.5793 · Cited by 64
Muižnieks, I., & Doerfler, W. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00394-7 · Cited by 45
Selection of Antisense Oligonucleotides on the Basis of Genomic Frequency of the Target Sequence
Han, J., Zhu, Z., Hsu, C., & Finley, W. H. (1994) · Antisense Research and Development · doi:10.1089/ard.1994.4.53 · Cited by 29
Hug, M., Silke, J., Georgiev, O., Rusconi, S., Schaffner, W., & Matsuo, K. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01521-3 · Cited by 28
Local sequence dependence of rate of base replacement in mammals
Bains, W. (1992) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(92)90109-f · Cited by 15
Cited by
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Self-citationTherapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Self-citationDNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
“Inhibitory sequences were originally discovered in adenoviral vectors 82 , and specific inhibitory motifs were subsequently identified by functional analyses of sequences related to a stimulatory motif 83 .”
BackgroundBarrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Metadata
- Authors
- Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-10-13
- Volume
- 95
- Issue
- 21
- Pages
- 12631-12636
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2054654286
- Cited by
- 397
- References
- 48
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.